ASX:BB1 ASX Announcement 19 November 2026 BlinkLab Receives $1.22 Million R&D Tax Incentive Refund Highlights ? $1,219,737 R&D Tax Incentive refund received. This non-dilutive funding comes on top of the $16.2 million cash balance reported at the end of the September 2026 quarter. ? The refund...
BlinkLab Receives $1.22 Million R&D Tax Incentive Refund
Filed with ASX · · 2 pages · English
Summary by 6ix AI
BlinkLab Limited has announced the receipt of a significant refund under the Australian Government’s R&D Tax Incentive program, which supports its ongoing research efforts. The refund is linked to the completion of a U.S. pilot study and the initiation of a pivotal program, along with clinical research collaborations in Australia. With a strong cash balance, BlinkLab is well-positioned to advance its pivotal study and seek FDA approval, which is crucial for entering the U.S. market. The funding will be utilized for further research and development activities, including clinical studies and regulatory processes.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from BlinkLab
- Positive Results in Genetic Autism Study Ahead of Schedule
- Trading Halt
- Quarterly Activities/Appendix 4C Cash Flow Report
- Commencement of Nationwide Autism Screening in Morocco
- BB1 to Present at Simons Foundation and ThinkEquity in NYC
Later from BlinkLab
All BlinkLab news releasesFollow BlinkLab into a list and get an email when it puts out news.
Follow BlinkLab